TheraRadar
Data updated: May 26, 2026

PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE (phentermine hydrochloride)

Metabolic Approved 2024-06-25

Phentermine hydrochloride helps patients with weight reduction when used for a short period of time alongside exercise, behavioral changes, and a low-calorie diet. It treats exogenous obesity in individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher who also have risk factors like diabetes, high blood pressure, or high cholesterol. Because its effectiveness is limited to a few weeks, it is used as a temporary addition to a broader weight management plan.

Source: FDA Label • Dr. Reddy's

How PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE Works

As a sympathomimetic amine, this medication works by mimicking the activity of amphetamines to support weight loss. While it is classified as an anorectic, its effects may involve various central nervous system actions or metabolic changes beyond simple appetite suppression.

Source: FDA Label
2
Indications
--
Phase 3 Trials
1
Years on Market

Details

Status
Prescription
First Approved
2024-06-25
Routes
ORAL
Dosage Forms
CAPSULE, EXTENDED RELEASE

Companies

Active Ingredient: PHENTERMINE HYDROCHLORIDE , TOPIRAMATE

PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE Approval History

2025
2026
Original
New Indication
New Form
Label Update
24 FDA actions from 2024 to 2026
May 2026 SUPPL
Label · Labeling
Jun 2025 ORIGINAL
Update
May 2025 SUPPL
Update · REMS

What PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE Treats

4 indications

PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE is approved for 4 conditions since its original approval in 2024. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Obesity
  • Hypertension
  • Diabetes
  • Hyperlipidemia
Source: FDA Label

PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
AMLODIPINE BESYLATE
2 shared
Apotex
Shared indications:
HypertensionHyperlipidemia
CADUET
AMLODIPINE BESYLATE
2 shared
PHARMACIA
Shared indications:
HypertensionHyperlipidemia
VYTORIN
EZETIMIBE
2 shared
Merck
Shared indications:
HyperlipidemiaDiabetes
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE FDA Label Details

Indications & Usage

PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE is indicated for the treatment of Obesity; Hypertension; Diabetes; Hyperlipidemia.

Track PHENTERMINE HYDROCHLORIDE AND TOPIRAMATE with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.